Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, plus a version bump to v3.2.0; removes the old v3.1.0 reference.SummaryDifference3% 
- Check32 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1% 
- Check46 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. A 'Back to Top' navigation element was removed, a minor UI change.SummaryDifference0.2% 
- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2% 
- Check60 days agoChange DetectedThe web page has been updated to include specific drug information for Tislelizumab and detailed location data for facilities in Beijing and Shanghai, while removing some redundant location terms and previous versions of the drug information.SummaryDifference4% 
- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1% 
Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.